Surveillance for isocyanate asthma: a model based cost effectiveness analysis - Wikidata - awgldk - TriplyDB

Surveillance for isocyanate asthma: a model based cost effectiveness analysis

Surveillance for isocyanate asthma: a model based cost effectiveness analysis

http://www.wikidata.org/entity/Q23911463

about

sameAs

Isocyanates and work-related asthma: findings from California, Massachusetts, Michigan, and New Jersey, 1993-2008 Identification of novel reaction products of methylene-bis-phenylisocyanate ("MDI") with oxidized glutathione in aqueous solution and also during incubation of MDI with a murine hepatic S9 fraction Progression from beryllium exposure to chronic beryllium disease: an analytic model Opportunities and obstacles in translating evidence to policy in occupational asthma Obstructive lung disease models: what is valid?Economic Evaluations of Public Health Surveillance Systems: a Systematic Review.Recent advances in the management of occupational asthma.An official American Thoracic Society proceedings: work-related asthma and airway diseases. Presentations and discussion from the Fourth Jack Pepys Workshop on Asthma in the Workplace.

P2860

Q23911590-F8207583-BA9F-4799-95F7-635097487DDE Q28388565-59F75AE6-836A-443F-A4DD-06335A1656C4 Q28389499-E4A6CC3F-6BD5-423C-8BEB-D8D1D534BC53 Q32944508-D434FDEA-75D6-4D52-A5DF-62DA513E0DB2 Q37437429-BAA6A78B-AEE4-4F00-BE54-E5353DB488B5 Q38724635-0C95921A-8C80-4635-AD11-88E214A15CF1 Q52600837-3AA48868-9D81-44A1-A033-F130C041871C Q54434643-5CFBBB16-FC7E-4007-91BB-110FF09F84AA

P2860

Surveillance for isocyanate asthma: a model based cost effectiveness analysis

http://www.wikidata.org/entity/Q23911463

description

2005 nî lūn-bûn

@nan

2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Surveillance for isocyanate asthma: a model based cost effectiveness analysis

@ast

Surveillance for isocyanate asthma: a model based cost effectiveness analysis

@en

Surveillance for isocyanate asthma: a model based cost effectiveness analysis

@en-gb

Surveillance for isocyanate asthma: a model based cost effectiveness analysis

@nl

type

label

Surveillance for isocyanate asthma: a model based cost effectiveness analysis

@ast

Surveillance for isocyanate asthma: a model based cost effectiveness analysis

@en

Surveillance for isocyanate asthma: a model based cost effectiveness analysis

@en-gb

Surveillance for isocyanate asthma: a model based cost effectiveness analysis

@nl

prefLabel

Surveillance for isocyanate asthma: a model based cost effectiveness analysis

@ast

Surveillance for isocyanate asthma: a model based cost effectiveness analysis

@en

Surveillance for isocyanate asthma: a model based cost effectiveness analysis

@en-gb

Surveillance for isocyanate asthma: a model based cost effectiveness analysis

@nl

P1433

Q23911463-85735A1A-62C3-4E26-B757-FA7B919CEB4B

P1476

Q23911463-52EAE6A1-BF49-4C0D-8824-AD055CDA5A8C

P2093

Q23911463-0DEC3163-5278-4F9F-B5A2-336B7BAA0149

Q23911463-26F464DF-006F-4CC4-BAE3-662877E2F5B4

P2860

Q23911463-13B3B095-67E8-4F96-AA2C-3603235AB4FD

Q23911463-176DD223-E277-4C00-9146-5DD4CCE8855E

Q23911463-24A235AC-1A62-4B16-8CF3-9B1F08513FBF

Q23911463-41ECFC89-959B-4082-BE11-6B52A04395EE

Q23911463-47143A32-9CFF-4D18-9EC2-26F991BC333C

Q23911463-48BCE032-03E8-48F7-9683-E629100B1B18

Q23911463-5CD2E39C-D7CF-4249-9ABB-834D462FD8D9

Q23911463-70075D47-9CC2-452E-88A6-0432F2242FBA

Q23911463-739F001E-21EF-418D-A4B4-DF2D0A3C2E81

Q23911463-766022C7-4C3C-4525-985A-19438FC2E75B

P2880

Q23911463-512937B5-A55D-4D5A-B9F5-F1AAF0234049

P304

Q23911463-B581F454-4E8D-4498-90BE-53B239F2074F

P31

Q23911463-3509DC30-3116-4C2A-AC5F-A27E140F7AFA

P356

Q23911463-620B089A-0C51-4CD3-8649-9161633290C9

P407

Q23911463-0DC6786B-0CF3-457B-B492-3CC8444BADAA

P433

Q23911463-4AAE10E2-AB90-46AC-A3A0-F11D8C52848D

P478

Q23911463-44109CB1-D0C4-40F9-AFBD-79446B8E18C5

P50

Q23911463-44E3AF08-7B42-470D-8C84-100D881B1473

P577

Q23911463-C5FC6576-7271-4BC5-BB31-442F0C72B7AC

P5875

Q23911463-CD4AF85D-3265-4989-AF2F-CB16572A4B94

P698

Q23911463-62382658-C804-48E7-9A17-17820820A60C

P859

Q23911463-CE36650C-A5AD-47B5-B3DA-785DB548F86C

P921

Q23911463-483DF759-42FF-4A82-878A-E61397A23F3A

Q23911463-5F887FB2-E16F-4A6A-A1A0-EA1724C095AC

Q23911463-B2E88A3B-802B-43F8-8961-C0321E99AC7D

Q23911463-B7973632-2B17-488A-B8C0-5ABAB02ECE7B

Q23911463-D44FDAE5-8F22-4CCA-891C-1B5555C307D7

P932

Q23911463-B9D5FD3A-7DFD-4ECE-9ACA-B47B76E34536

P356

OEM.2004.016147

P1433

Occupational and Environmental Medicine

P1476

Surveillance for isocyanate asthma: a model based cost effectiveness analysis

@en

P2093

C A Redlich

http://www.w3.org/2001/XMLSchema#string

D M Wild

http://www.w3.org/2001/XMLSchema#string

P2860

A case series of 71 patients referred to a hospital-based occupational and environmental medicine clinic for occupational asthma

Risk and incidence of asthma attributable to occupational exposure among HMO members

The work impact of asthma and rhinitis: findings from a population-based survey

Outcome determinants for isocyanate induced occupational asthma among compensation claimants.

Can We protect workers from developing the adverse respiratory effects of isocyanate exposure?

A comprehensive league table of cost-utility ratios and a sub-table of "panel-worthy" studies.

Diisocyanate asthma: clinical aspects and immunopathogenesis.

Frequency and trends of occupational asthma due to toluene diisocyanate: a critical review.

Diisocyanate-induced asthma: diagnosis, prognosis, and effects of medical surveillance measures.

New developments in work-related asthma.

P2880

20029036

http://www.w3.org/2001/XMLSchema#string

P304

743-749

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/OEM.2004.016147

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P50

A. David Paltiel

P577

2005-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7532830

http://www.w3.org/2001/XMLSchema#string

P698

16234399

http://www.w3.org/2001/XMLSchema#string

P859

National Institute for Occupational Safety and Health

P921

occupational asthma

respiratory disease

workplace health surveillance

P932

1740898

http://www.w3.org/2001/XMLSchema#string